{
    "ticker": "RNXT",
    "name": "Renovaro Biosciences, Inc.",
    "description": "Renovaro Biosciences, Inc. is a biotechnology company focused on developing innovative therapies for chronic diseases and conditions that significantly impact patients' quality of life. Established with the vision of harnessing advanced regenerative medicine techniques, Renovaro aims to transform patient care through the development of cutting-edge treatments that utilize stem cell technology and other regenerative approaches. The company's primary focus is on harnessing the potential of regenerative medicine to restore function and enhance the healing process in various medical conditions. Renovaro is dedicated to advancing its proprietary cell-based therapies, which target areas such as orthopedic, neurological, and degenerative diseases. By leveraging scientific research and clinical expertise, Renovaro strives to provide effective solutions that address unmet medical needs. The company is committed to maintaining high standards of safety and efficacy in its product development and regulatory processes. Renovaro\u2019s mission is to improve the lives of patients by delivering innovative therapies that not only treat symptoms but also tackle the underlying causes of chronic illnesses.",
    "industry": [
        "Biotechnology",
        "Healthcare"
    ],
    "headquarters": "Las Vegas, Nevada, USA",
    "founded": "2019",
    "website": "https://www.renovarobio.com",
    "ceo": "David Koos",
    "social_media": {
        "twitter": "https://twitter.com/RenovaroBio",
        "linkedin": "https://www.linkedin.com/company/renovaro-biosciences"
    },
    "investor_relations": "https://www.renovarobio.com/investors",
    "key_executives": [
        {
            "name": "David Koos",
            "position": "CEO"
        },
        {
            "name": "Michael T. Hurst",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Regenerative Therapies",
            "products": [
                "Stem Cell Treatments",
                "Orthopedic Solutions"
            ]
        }
    ],
    "seo": {
        "meta_title": "Renovaro Biosciences, Inc. | Innovative Regenerative Therapies",
        "meta_description": "Explore Renovaro Biosciences, Inc., a leader in regenerative medicine focused on developing advanced therapies for chronic diseases. Discover our innovative solutions.",
        "keywords": [
            "Renovaro",
            "Regenerative Medicine",
            "Stem Cell Therapy",
            "Biotechnology",
            "Chronic Diseases"
        ]
    },
    "faq": [
        {
            "question": "What is Renovaro Biosciences known for?",
            "answer": "Renovaro Biosciences is known for developing innovative regenerative therapies using stem cell technology."
        },
        {
            "question": "Who is the CEO of Renovaro Biosciences?",
            "answer": "David Koos is the CEO of Renovaro Biosciences, Inc."
        },
        {
            "question": "Where is Renovaro headquartered?",
            "answer": "Renovaro is headquartered in Las Vegas, Nevada, USA."
        },
        {
            "question": "What types of therapies does Renovaro develop?",
            "answer": "Renovaro develops regenerative therapies targeting chronic diseases, particularly in orthopedic and neurological areas."
        },
        {
            "question": "When was Renovaro founded?",
            "answer": "Renovaro was founded in 2019."
        }
    ],
    "competitors": [
        "ATNF",
        "AMRN",
        "CRIS"
    ],
    "related_stocks": [
        "NVAX",
        "PFE",
        "MRNA",
        "BMY"
    ]
}